RenovoRx RNXT
NASDAQ RNXT
$1.23 +0.03 (+2.50%)
At close: Oct 21, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Debt Ratio (2020)

Updated

RenovoRx's Debt Ratio was 1.38 in Q4 2020.

Analysis

RenovoRx (RNXT) Debt Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 0.38
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 0.30
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 0.29
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn -
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 0.30
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 0.31
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 0.28
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 0.33
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 0.04
10 RenovoRx 58.89 Mn 19.92 Mn 766,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 1.38
API Access

RenovoRx Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RNXT&period=max&api_key=YOUR_API_KEY